Optimizing Care Transition Process for Older Colorectal Surgery Patients
Launched by MASSACHUSETTS GENERAL HOSPITAL · Dec 20, 2024
Trial Information
Current as of June 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving the care and support that older adults receive after they undergo colorectal surgery, which is a procedure related to the colon or rectum. The study aims to test a special program designed to help these patients transition smoothly from the hospital back to their homes. By doing this, researchers hope to see if patients have better health outcomes after they leave the hospital.
To participate in this trial, individuals must be at least 65 years old and scheduled for a planned colorectal surgery. It's important that they can understand and agree to be part of the study. Unfortunately, patients who need emergency surgery or who do not speak English will not be eligible. If someone joins the trial, they can expect to receive extra support during their recovery process, which may help improve their overall experience after surgery. This study is currently not recruiting participants, but it represents an important step toward better care for older adults undergoing surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients (\>65 years old)
- • Scheduled to undergo an elective colorectal surgery procedure
- • Ability to provide informed consent
- Exclusion Criteria:
- • Emergent, non-elective colorectal procedures
- • Non-English Speaking
About Massachusetts General Hospital
Massachusetts General Hospital (MGH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing medical research and patient care. As a prominent teaching hospital affiliated with Harvard Medical School, MGH plays a pivotal role in clinical trials across a wide range of disciplines, including cardiology, oncology, neurology, and more. The institution is dedicated to fostering innovative research that translates into effective therapies and improved health outcomes. MGH's Clinical Trials Office provides comprehensive support to facilitate the design, implementation, and management of clinical studies, ensuring adherence to the highest ethical standards and regulatory compliance. With a focus on collaboration and patient-centered care, MGH strives to enhance medical knowledge and contribute to the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported